A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE)

MLA

Agostino Cortelezzi, et al. “A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE).” Blood, vol. 122, Nov. 2013, p. 3967. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........80fbe0a0a8f19d203a39b7ff93d55bff&authtype=sso&custid=ns315887.

APA

Agostino Cortelezzi, Nicola Cascavilla, Pietro Leoni, Alessandra Freyrie, Stella Santarone, Anna Candoni, Patrizia Cufari, Prassede Salutari, Caterina Alati, Fortunato Morabito, Debora Capelli, Bruno Martino, Pellegrino Musto, Francesco Di Raimondo, Paolo Bartolomeo, Francesca Ronco, Irene Santacaterina, Antonio Volpe, Esther Oliva, & Iolanda Vincelli. (2013). A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE). Blood, 122, 3967.

Chicago

Agostino Cortelezzi, Nicola Cascavilla, Pietro Leoni, Alessandra Freyrie, Stella Santarone, Anna Candoni, Patrizia Cufari, et al. 2013. “A Randomized Open-Label Study To Evaluate The Efficacy Of Azacitidine For Post-Remission Therapy Of Acute Myeloid Leukemia In Elderly Patients (QOLESS AZA-AMLE).” Blood 122 (November): 3967. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........80fbe0a0a8f19d203a39b7ff93d55bff&authtype=sso&custid=ns315887.